Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Blood
|
June 1, 1996
Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow
T L Holyoake, M G Freshney, L McNair, et al.
Leukemia
|
May 13, 2005
Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro
H G Jørgensen, E K Allan, S M Graham, et al.
Bone Marrow Transplantation
|
October 26, 2005
Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT)
M Cummins, K Cwynarski, S Marktel, et al.
Leukemia
|
March 6, 2009
A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response
M W Drummond, N Heaney, J Kaeda, et al.
Clinical Pharmacology and Therapeutics
|
September 5, 2014
Dual glutathione-S-transferase-θ1 and -μ1 gene deletions determine imatinib failure in chronic myeloid leukemia
A Davies, A Giannoudis, J E Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity
M J Alcorn, T L Holyoake, L Richmond, et al.
Bone Marrow Transplantation
|
January 11, 2005
A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients
N E Jordanides, E K Allan, L A McLintock, et al.
Stem Cells (Dayton, Ohio)
|
October 1, 1993
Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro
T L Holyoake, M G Freshney, A M Sproul, et al.
Leukemia
|
August 28, 2009
Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters
A Davies, N E Jordanides, A Giannoudis, et al.
Blood Cancer Journal
|
July 26, 2012
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells
G Manzotti, S A Mariani, F Corradini, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Blood
|
June 1, 1996
Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow
T L Holyoake, M G Freshney, L McNair, et al.
Leukemia
|
May 13, 2005
Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro
H G Jørgensen, E K Allan, S M Graham, et al.
Bone Marrow Transplantation
|
October 26, 2005
Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT)
M Cummins, K Cwynarski, S Marktel, et al.
Leukemia
|
March 6, 2009
A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response
M W Drummond, N Heaney, J Kaeda, et al.
Clinical Pharmacology and Therapeutics
|
September 5, 2014
Dual glutathione-S-transferase-θ1 and -μ1 gene deletions determine imatinib failure in chronic myeloid leukemia
A Davies, A Giannoudis, J E Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity
M J Alcorn, T L Holyoake, L Richmond, et al.
Bone Marrow Transplantation
|
January 11, 2005
A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients
N E Jordanides, E K Allan, L A McLintock, et al.
Stem Cells (Dayton, Ohio)
|
October 1, 1993
Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro
T L Holyoake, M G Freshney, A M Sproul, et al.
Leukemia
|
August 28, 2009
Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters
A Davies, N E Jordanides, A Giannoudis, et al.
Blood Cancer Journal
|
July 26, 2012
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells
G Manzotti, S A Mariani, F Corradini, et al.
Page
of 7